Almost 150 will leave Coloplast

The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

How to be a perfect mingler

Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...

LEO Pharma - International Clinical Trial Manager

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...

Så ska USA satsa på life science

I president Obamas budgetförslag för år 2016 nämns bland annat en satsning mot spridningen av antibiotikaresistens och ett initiativ för individanpassad medicin.

Gates satsar på Crispr

Microsoft-grundaren finansierar genterapibolaget Editas Medicine.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Glucose facilitates the use of indigo

The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.

Swedish multi competent machine soon launched

The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.

Clinical trials in large scale to Stockholm

Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...

Acadia drug awarded

Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.

Bioreactor features disposable sensors

The Biostat Cultibag STR line of bioreactors from Sartorius-Stedim features disposable components to reduce risk of contamination.

Respiratorius hunts millions

The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.

New partnering platform

EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.

Satsar på modifierade antikroppar

Antikroppskonjugat är en av nästa generations antikroppstekniker. De kan användas för en målinriktad behandling, exempelvis vid cancer.

Esteya får grönt ljus i USA

Elektas nya behandlingssystem för behandling av hudcancer får klartecken att lanseras på den amerikanska marknaden.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

BMAs: Run your own business

After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Pronova Biopharma grows

Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark

KI i open innovation-samarbete

Genom projektet Ultra-DD ska tidig läkemedelsutveckling bli mer effektiv.